Boost to melanoma support in WA

Boost to melanoma support in WA

31 January 2020

Melanoma patients and their families across Western Australia will benefit from strengthened and expanded services with the merging of melanomaWA and Melanoma Institute Australia.

One Australian dies from melanoma every five hours and WA is second only to QLD in terms of melanoma incidence across Australia.

Chairman of melanomaWA, Martin Slabbert, said the merger with Melanoma Institute Australia was exciting and would have widespread benefits for the entire West Australian community.

‘The two highly respected organisations will be working together on a regional and national level regarding awareness, education, support, and research,’ Mr Slabbert said.

‘Importantly, the alignment will also provide local, regional, and remote melanoma patients with greater access to medical specialists through Melanoma Institute Australia’s network. This coordinated approach has been well received by patients connected with melanomaWA.’

CEO of Melanoma Institute Australia, Matthew Browne, said the merger would ensure increased resources dedicated to reducing the impact of melanoma on the community in WA.

‘Melanoma Institute Australia is delighted to be merging with melanomaWA,’ Mr Browne said. ‘Melanoma is, unfortunately, Australia’s national cancer and accordingly combining organisations from west coast and the east coast gives us all the best chance of fighting this disease.

‘Joining two strong melanoma organisations immediately brings increased resources and services to melanoma patients as well as a broader coordinated reach in raising awareness about early detection and prevention strategies including sun safety.’

The first fundraising and awareness event of the combined entity will be Melanoma March which will be held in Bunbury on 15th March and at Perth’s Cottesloe Beach on 29th March. Funds raised from the family-friendly Melanoma March events will support melanoma research to pave the way for new and life-saving treatments.

A meeting of the minds
02 Jun 2016

A meeting of the minds

MIA's doctors are converging on Chicago this week along with 40,000 delegates from around the globe at the biggest oncology conference in the world.

MIA's Dermatology services expanded
27 May 2016

MIA's Dermatology services expanded

We are pleased to announce a recent expansion to the dermatology services at Melanoma Institute Australia.

5 Minutes with Maria Gonzalez
20 May 2016

5 Minutes with Maria Gonzalez

This International Clinical Trials Day we reflect on the importance of clinical trials and the people who dedicate their lives to helping melanoma patients today and in the future.

Melanoma eBook to educate GPs
12 May 2016

Melanoma eBook to educate GPs

MIA has launched its first eBook Melanoma Essentials – A Concise Guide, a resource for GPs and other medical, nursing and allied professionals to help them effectively diagnose and manage cases.

5 Minutes with Dr Scot Ebbinghaus
05 May 2016

5 Minutes with Dr Scot Ebbinghaus

Dr Scot Ebbinghaus chats to us about an exciting clinical trial at MIA and where melanoma treatment is headed in the future.

Opdivo available on PBS for advanced melanoma patients
01 May 2016

Opdivo available on PBS for advanced melanoma patients

A new melanoma treatment has been listed on the PBS today, giving another option for advanced melanoma patients. 

5 Minutes with Dr Louise Jackett
27 Apr 2016

5 Minutes with Dr Louise Jackett

MIA's Pathology Fellow Dr Louise Jackett tells us why she's joined our fellowship program to learn from the best.

MIA patient's plight highlighted in ABC series
27 Apr 2016

MIA patient's plight highlighted in ABC series

MIA doctors and patient have featured in the final episode of ABC’s ground-breaking series Keeping Australia Alive.

Recruiting: Pregnancy and moles study
26 Apr 2016

Recruiting: Pregnancy and moles study

Specialist dermatologists at MIA are researching moles during pregnancy and we are looking for study recruits.

The role of radiotherapy in melanoma
22 Apr 2016

The role of radiotherapy in melanoma

New research is re-writing the textbooks on what we know about melanoma by highlighting the effectiveness of radiotherapy as a treatment, reversing a long-held belief that melanoma was resistant to radiotherapy.

Australian melanoma rates take the silver – and that's good news
31 Mar 2016

Australian melanoma rates take the silver – and that's good news

However, Australia's burden of melanoma will stay very high over the next 15 years unless we do more. MIA's Professor Graham Mann explains.

Australia unites taking small steps to make a big difference for melanoma research
23 Mar 2016

Australia unites taking small steps to make a big difference for melanoma research

Thank you to everyone involved in making Melanoma March 2016 a huge success

And they're off... Melanoma March 2016 begins!
29 Feb 2016

And they're off... Melanoma March 2016 begins!

Melanoma March 2016 has officially begun with more than 300 people marching in Rockingham and Devonport.

5 Minutes with Carole Renouf
29 Feb 2016

5 Minutes with Carole Renouf

MIA's new CEO Carole Renouf has been in her role only a month, but is already making plans for the future of MIA.

Opinion: Outing Melanoma
24 Feb 2016

Opinion: Outing Melanoma

In the wake of Susie Maroney's recent announcement that she is battling melanoma, CEO Carole Renouf's opinion piece weighs in on the critical need we have in Australia to raise awareness about melanoma. 

Congratulations Professor Georgina Long
22 Feb 2016

Congratulations Professor Georgina Long

MIA's Georgina Long has been appointed Professor and awarded a coverted prize in medial research.

Melanoma March 2016: Where your funds are going
19 Feb 2016

Melanoma March 2016: Where your funds are going

Melanoma March 2016 funding will be used to initiate an ambitious new project that will support the best possible care for melanoma patients around Australia through a new data and communication platform. 

New research shows long-term survival in group of advanced melanoma patients treated with BRAF inhibitors
05 Feb 2016

New research shows long-term survival in group of advanced melanoma patients treated with BRAF inhibitors

New MIA-led research has been published in the Journal of Clinical Oncology.

Melanoma March 2016 is launched
02 Feb 2016

Melanoma March 2016 is launched

Melanoma March was officially launched today with the announcement of the national research project funded by the march. 

MIA's research pivotal in TGA's approval of new therapy
01 Feb 2016

MIA's research pivotal in TGA's approval of new therapy

Clinical research undertaken at MIA has been pivotal in supporting the recent Therapeutic Goods Administration approval of Opdivo (nivolumab) for advanced melanoma.